MiraLAX 17g Every 12 Hours: Not the Standard Dosing
The FDA-approved and guideline-recommended dose of MiraLAX (polyethylene glycol 3350) is 17 g once daily, not every 12 hours. 1 Administering 17 g every 12 hours would result in a total daily dose of 34 g, which is double the approved dose and lacks supporting evidence for routine use.
FDA-Approved Dosing
The FDA label for MiraLAX clearly specifies 17 g once daily for occasional constipation 1. This is the dose that has been validated in clinical trials and approved for over-the-counter use.
Evidence-Based Dosing from Guidelines
The 2023 AGA-ACG guidelines strongly recommend PEG 3350 for chronic idiopathic constipation, but the evidence base supports 17 g once daily 2:
- The largest U.S. trial (n=304) used 17 g once daily for 6 months and demonstrated significant efficacy with moderate certainty of evidence 2
- Two Italian studies used 17.5 g of PEG with electrolytes twice daily (total 35 g/day), but this was a different formulation that included electrolytes 2
Key Distinctions
PEG 3350 without electrolytes (MiraLAX): 17 g once daily is the standard dose 2
PEG 3350 with electrolytes: Some studies used twice-daily dosing (17.5 g BID), but this is a different preparation 2
Clinical Efficacy at Standard Dosing
At the approved 17 g once daily dose, PEG 3350 demonstrated 2:
- Increase of 2.9 complete spontaneous bowel movements per week vs placebo
- 42% of patients met FDA responder criteria over 24 weeks 3
- Durable response maintained for up to 12 months 4
- Well-tolerated with primarily mild GI side effects (diarrhea, flatulence, nausea)
When Higher Doses May Be Considered
While 17 g once daily is standard, the evidence shows:
- Dose titration is permitted in clinical practice, with upper limits studied up to 41.1 g/day in some trials 5
- However, this should be done as a gradual titration based on response, not as an automatic twice-daily regimen
- Start at 17 g daily and increase only if inadequate response after an appropriate trial period
Common Pitfalls
- Don't automatically double the dose: The twice-daily regimens in studies used PEG with electrolytes, not standard MiraLAX
- Risk of diarrhea increases with higher doses: The most common adverse effect is loose stools/diarrhea, which would be more likely at 34 g/day 2
- No evidence for routine BID dosing: The strong recommendation from guidelines is based on once-daily dosing 2
Practical Recommendation
Start with 17 g once daily mixed in 8 ounces of liquid 2. If response is inadequate after 1-2 weeks, consider:
- Ensuring adequate fluid intake
- Adding or optimizing fiber supplementation
- Gradually increasing the PEG dose rather than immediately doubling to BID dosing
- Evaluating for other causes of refractory constipation
The 17 g every 12 hours regimen lacks evidence support and doubles the FDA-approved dose without clear benefit, while potentially increasing adverse effects.